Mediwound

MDWD NASDAQ
3.610
+0.200
+5.85%
Opening 10:30 07/19 EDT
Open
3.430
Prev Close
3.410
High
3.700
Low
3.430
Volume
24.48K
Avg Vol (3M)
76.60K
52 Week High
6.75
52 Week Low
3.000
% Turnover
0.09%
Market Cap
98.10M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Mediwound MDWD stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

MediWound Ltd. is a biopharmaceutical company. The Company focuses on developing, manufacturing and commercializing therapeutics products in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders and other indications. The Company's product, NexoBrid, is indicated for the removal of dead or damaged tissue, known as eschar, in adults with deep partial- and full-thickness thermal burns, also referred to as severe burns. The Company sells NexoBrid in Europe and Israel. NexoBrid is a topically-applied product that removes eschar in four hours without harming the surrounding healthy tissues. Its product, EscharEx, is a topical biological drug, which is being developed for debridement of chronic and other hard-to-heal wounds. NexoBrid and EscharEx are based on its proteolytic enzyme technology. The Company is also developing an injectable product based on its proteolytic enzyme technology for connective tissue pathologies and indications.
MORE >

Recently

Name
Price
%Change